<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-2012-26-10-8</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-26-10-8</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Seizure Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Etiology and Prognosis of Neonatal Convulsions</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Ann &#x0026; Robert H. Lurie Children&#x0027;s Hospital of Chicago, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1">
<label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>10</month>
<year>2012</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>11</month>
<year>2015</year>
</pub-date>
<volume>26</volume>
<issue>10</issue>
<fpage>79</fpage>
<lpage>79</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2012 The Author(s)</copyright-statement>
<copyright-year>2012</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1016/j.pediatrneurol.2012.05.015" vol="47" page="186">
<article-title>Evaluation of etiologic and prognostic factors in neonatal convulsions</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>Researchers at Istanbul University, Turkey evaluated etiologic and risk factors affecting long-term neurologic outcome in newborns with neonatal seizures.</p>
</abstract>
<kwd-group>
<kwd>Apgar Score</kwd>
<kwd>Resuscitation at Birth</kwd>
<kwd>Abnormal EEG</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Researchers at Istanbul University, Turkey evaluated etiologic and risk factors affecting long-term neurologic outcome in newborns with neonatal seizures. Of 112 newborns referred to the Department of Pediatric Neurology from Jan 1, 2007-Dec 31, 2009, 33 were preterm and 79 full-term (41 female, 71 male). The rate of seizures within the first 24 hours was higher following perinatal asphyxia (p=0.0001). Status epilepticus occurred in 26 patients (23.2%). Seizures were tonic in 21 patients (18.8%), subtle in 18 (16.1%), myoclonic in 15 (13.4%), and clonic in 15 (13.4%). EEG was normal or slightly abnormal in 69 patients (61.6%), and very abnormal in 16 (14.3%). Cranial imaging detected parenchymal hemorrhage in 22 cases (19.7%). Seizures responded to phenobarbital in 73 patients (65.2%). Etiologic factors included perinatal asphyxia in 22 cases (28.6%), intracranial bleeding in 19 (17%), metabolic disease in 12 (10.7%), unknown in 10 (8.9%), and miscellaneous. Prognosis was poorer in patients with perinatal asphyxia compared to those with metabolic disorders or unknown etiology. Epilepsy and global developmental delay, low Bayley cognitive and motor scores, and low language scores were more frequent following perinatal asphyxia compared to the group with metabolic disease or seizures of unknown etiology. Epilepsy developed in 35.7% patients, cerebral palsy in 27.6%, and global developmental delay in 50.8%. Prognostic factors in neurologic outcome included etiology, Apgar score, resuscitation at birth, abnormal EEG, neonatal status epilepticus, duration of AEDs, and response to acute treatment. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p>COMMENT. Perinatal asphyxia is the most common cause of neonatal seizures and a risk factor for epilepsy, cerebral palsy and developmental delay. In one previous study of prognostic factors in 120 term infants with neonatal seizures, the prevalence of epilepsy, cerebral palsy and global developmental delay was 32%, 31%, and 43%, respectively [<xref ref-type="bibr" rid="CIT0002">2</xref>]. It is unclear whether the cognitive impairment and developmental delay are in part the result of seizures or AED side effects. A small but significant depressant effect of long-term phenobarbital on cognitive function of children with febrile seizures is well known [<xref ref-type="bibr" rid="CIT0003">3</xref>]. Duration of AEDs was a prognostic risk factor in outcome in the present study. Further controlled studies of the long-term effects of AEDs on patients with neonatal seizures and epilepsy are required.</p>
<p>Status epilepticus and EEG abnormalities in the first year of life predict worse developmental outcome in children with Dravet syndrome also, complications that may be amenable to more specific therapy [<xref ref-type="bibr" rid="CIT0004">4</xref>]. Dravet syndrome is a form of epilepsy associated with cognitive and motor disorders, resulting in encephalopathy. [<xref ref-type="bibr" rid="CIT0005">5</xref>]</p>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yildiz</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Tatli</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ekici</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Eraslan</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Aydinli</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Caliskan</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Evaluation of etiologic and prognostic factors in neonatal convulsions</article-title>
<source>Pediatr Neurol</source>
<year>2012</year>
<month>Sep</month>
<volume>47</volume>
<issue>3</issue>
<fpage>186</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2012.05.015</pub-id>
<pub-id pub-id-type="pmid">22883283</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garfinkle</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shevell</surname>
<given-names>MI</given-names>
</name>
</person-group>
<article-title>Cerebral palsy, developmental delay, and epilepsy after neonatal seizures</article-title>
<source>Pediatr Neurol</source>
<year>2011</year>
<month>Feb</month>
<volume>44</volume>
<issue>2</issue>
<fpage>88</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2010.09.001</pub-id>
<pub-id pub-id-type="pmid">21215907</pub-id>
</element-citation>
</ref>
<ref id="CIT0003">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farwell</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Hirtz</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Sulzbacher</surname>
<given-names>SI</given-names>
</name>
<name>
<surname>Ellenberg</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>KB</given-names>
</name>
</person-group>
<article-title>Phenobarbital for febrile seizures-effects on intelligence and on seizure recurrence</article-title>
<source>N Engl J Med</source>
<year>1990</year>
<month>Feb</month>
<day>8</day>
<volume>322</volume>
<issue>6</issue>
<fpage>364</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM199002083220604</pub-id>
<pub-id pub-id-type="pmid">2242106</pub-id>
</element-citation>
</ref>
<ref id="CIT0004">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brunklaus</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Reavey</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Forbes</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Zuberi</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome</article-title>
<source>Brain</source>
<year>2012</year>
<month>Aug</month>
<volume>135</volume>
<issue>Pt 8</issue>
<fpage>2329</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1093/brain/aws151</pub-id>
<pub-id pub-id-type="pmid">22719002</pub-id>
</element-citation>
</ref>
<ref id="CIT0005">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dravet</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>How Dravet syndrome became a model for studying childhood genetic epilepsies</article-title>
<source>Brain</source>
<year>2012</year>
<month>Aug</month>
<volume>135</volume>
<issue>Pt 8</issue>
<fpage>2309</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1093/brain/aws198</pub-id>
<pub-id pub-id-type="pmid">22843408</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
